ENTITY

Argenx SE (ARGX US)

44
Analysis
Health CareNetherlands
argenx SE operates as a biotechnology company. The Company develops antibody based therapies for the treatment of severe autoimmune diseases and cancer. argenx serves customers in the Netherlands and Belgium.
more
01 Oct 2024 08:36Issuer-paid

Biopharma Week in Review - September 30, 2024

We review last week’s biopharma news for meaningful clinical data, regulatory updates, research innovation, and M&A. Last week, BMY received...

Logo
184 Views
Share
02 Jul 2024 05:19Issuer-paid

Biopharma Week in Review - July 1, 2024

We review last week’s biopharma news for meaningful clinical data, regulatory updates, research innovation, and M&A.

Logo
166 Views
Share
x